Navigation Links
Updated agenda available for Optimizing PCI Outcomes Symposium
Date:3/29/2011

WHAT & WHY: The updated agenda for the Optimizing PCI Outcomes: Challenges in 2011 symposium is now available at: http://www.pcioutcomes.com/conference/agenda.html. This evening symposium will feature the latest clinical and experimental breakthroughs in the percutaneous treatment of coronary artery disease, including the data on current and second-generation drug-eluting stent device-based therapies. Controversies, including resistance and selection, of antiplatelet therapy as adjunctive treatment with percutaneous intervention will be discussed along with the use of imaging tools and how to manage complex lesions.

Presentations will focus on:

  • Who Should Undergo Angiography? Integrating Symptoms and Noninvasive Testing
  • Cath Lab Decisions in Patients With and Without Noninvasive Tests: Use of Angiography and IVUS; Use and Interpretation of FFR in Simple and Complex Lesions
  • How to Prevent Stent Thrombosis (First and Second Occurrences)
  • PCI for Left Main Disease
  • Pharmacology Challenges

WHEN:
April 2, 2011
5:00 PM-9:00 PM

WHERE:
Hilton New Orleans Riverside
#2 Poydras Street
New Orleans, LA 70130

This event is not part of the official ACC Annual Scientific Session and/or the American College of Cardiology's Innovation in Intervention: i2 Summit in partnership with the Cardiovascular Research Foundation (CRF) as planned by their Program Committees.

For more information visit: http://www.pcioutcomes.com/home.html

HOW TO REGISTER: Media may apply for registration by visiting: http://www.pcioutcomes.com/conference/press-registration.html


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. Updated heart disease prevention guidelines for women focus more on real-world recommendations
2. Vitamin D and calcium -- updated dietary reference intakes from IOM
3. How We Die, award-winning classic, updated for 2010
4. Updated resource guide for internists released by ACP
5. ESMO publishes updated guidelines on cancer care
6. Updated HIV therapy guidelines would reduce risk of transmission, save lives, billions in costs
7. Shoot 1UP, Popular Xbox 360 Action Game, Updated for Disabled Gamers
8. EAU launches new and updated clinical guidelines for 2010
9. Lawrence Berkeley National Laboratory and OpenHelixTM Announce an Updated Free Tutorial Suite for VISTA: Tools for Comparative Genomics
10. Agenda set for upcoming global conference on stem cell therapy to be held Jan. 20-21, 2011
11. Transformation at top of agenda for CPMRCs annual conference in Jan. 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Reflections Recovery ... now accredited by The Joint Commission for chemical dependency and behavioral health services. ... U.S. health care organizations that meet the commission’s rigorous standards. Accreditation by The ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... Clinical Plus Coating System for clients that rely on safety and cleanliness. This ... of microorganisms. , Silver has been used for centuries for its antimicrobial properties. ...
(Date:9/20/2017)... ... 2017 , ... Renal Support Network’s annual essay contest celebrates ... The theme “Describe a positive decision that you have made about your healthcare” ... one qualification— to have been diagnosed with chronic kidney disease. This year the ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... medical device compliance and commercialization, has just released a new white paper ... is more adamant than ever about medical device, pharmaceutical, and combination product ...
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer ... East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes ... 40 speakers — representing such thought-leading companies as JP Morgan Chase, GE ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
(Date:8/31/2017)... -- PM360,s annual Innovations Issue, published in December, ... happening across the industry. Established six years ago, this ... a comprehensive look at the newest and most exciting ... companies, startups, divisions, products, services, and strategies from the ... in this industry wants to do better—in all facets ...
Breaking Medicine Technology: